nct02637284 bpc-157 status A human trial was registered. The results were submitted. Then they disappeared from public view. In 2015, a Phase I, randomized, placebo-controlled clinical trial (NCT02637284) was launched Detection and in vitro metabolism
Description
Beim Menschen liegen mehrere erste Datenpunkte vor: Eine Phase-II-Studie zu Colitis ulcerosa verlief ohne Nebenwirkungen

The rest

Evidence is preliminary, and it is not an FDA-approved treatment for any medical condition

Discover the benefits of combining semaglutide with B12
BPC-157 supports tissue repair while TRT provides the anabolic hormonal environment for recovery
Diabetes Care 36 , 36843690 (2013)
